Related Experiment Video
Updated: Mar 11, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Didymin induces apoptosis through mitochondrial dysfunction and up-regulation of RKIP in human hepatoma cells
Jinbin Wei1, Quanfang Huang2, Facheng Bai1
1Guangxi Medical University, Nanning 530021, China.
Abstract:
In the present study, a flavonoid was isolated from Origanum vulgare and identified as didymin. The effect and mechanism of O. vulgare didymin (OVD) on human HepG2 liver carcinoma cell was then assessed. Our results showed that OVD strongly inhibited the viability, clonogenicity and migration of HepG2 cells. OVD significantly induced apoptosis and induced cell cycle arrest at G2/M phase by regulating cyclin B1, cyclin D1 and CDK4. The anti-proliferative and pro-apoptotic effects were associated with changes in the Bcl-2/Bax ratio and induction of caspase-mediated apoptosis. Moreover, OVD attenuated the mitochondrial membrane potential, accompanied by the release of cytochrome c. In addition, OVD inhibited the ERK/MAPK and PI3K/Akt pathways by increasing the level of Raf kinase inhibitor protein (RKIP). Our study indicates that OVD induces apoptosis against of HepG2 cells through mitochondrial dysfunction and inactivation of the ERK/MAPK and PI3K/Akt pathways by up-regulating RKIP.
Insights
Origanum vulgare didymin (OVD) effectively inhibits liver cancer cell growth and migration. This flavonoid induces apoptosis and cell cycle arrest by impacting key molecular pathways and mitochondrial function.
Area of Science:
- Phytochemistry
- Molecular Biology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Natural compounds offer potential therapeutic avenues for cancer treatment.
- Origanum vulgare is a medicinal herb with known bioactive constituents.
Purpose of the Study:
- To investigate the anti-cancer effects of didymin isolated from Origanum vulgare (OVD) on human HepG2 liver carcinoma cells.
- To elucidate the underlying molecular mechanisms of OVD-induced anti-cancer activity.
Main Methods:
- Isolation and identification of didymin from Origanum vulgare.
- Assessment of OVD's effects on HepG2 cell viability, clonogenicity, and migration.
- Analysis of cell cycle progression and apoptosis induction.
- Evaluation of mitochondrial membrane potential and cytochrome c release.
- Investigation of signaling pathways, including ERK/MAPK, PI3K/Akt, and RKIP levels.
Main Results:
- OVD significantly inhibited HepG2 cell viability, clonogenicity, and migration.
- OVD induced G2/M phase cell cycle arrest by regulating cyclin B1, cyclin D1, and CDK4.
- OVD promoted apoptosis via modulation of the Bcl-2/Bax ratio and caspase activation.
- OVD attenuated mitochondrial membrane potential and induced cytochrome c release.
- OVD inhibited ERK/MAPK and PI3K/Akt pathways by up-regulating RKIP.
Conclusions:
- Origanum vulgare didymin (OVD) exhibits potent anti-cancer properties against HepG2 liver carcinoma cells.
- OVD induces apoptosis and cell cycle arrest through mitochondrial dysfunction and inactivation of key signaling pathways.
- Up-regulation of RKIP by OVD plays a crucial role in inhibiting ERK/MAPK and PI3K/Akt pathways.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway

